Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
2000 · Oncogene · 628 citations
https://doi.org/10.1038/sj.onc.1203973
Y
Y Yarden
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
2.2K
Citations
11
h-index
11
i10-index
Y Yarden is an academic researcher from Weizmann Institute of Science. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Cancer-related Molecular Pathways. The author has an h-index of 11, co-authored 15 publications.
Papers by this author
worksNeural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.
1993 · Proceedings of the National Academy of Sciences · 116 citations
https://doi.org/10.1073/pnas.90.5.1867
Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase
1994 · Cancer treatment and research · 28 citations
https://doi.org/10.1007/978-1-4615-2592-9_9
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
1992 · The Journal of Steroid Biochemistry and Molecular Biology · 24 citations
https://doi.org/10.1016/0960-0760(92)90192-l
Present and future breast cancer management—bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
2013 · Annals of Oncology · 7 citations
https://doi.org/10.1093/annonc/mdt531
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat